We are live on ! Find out more
FMI

F/M Investments Portfolio holdings

AUM $1.97B
1-Year Est. Return 30.33%
This Fund
S&P 500
This Quarter Est. Return
+12.59%
1 Year Est. Return
+30.33%
3 Year Est. Return
+101.46%
5 Year Est. Return
+144.03%
10 Year Est. Return
AUM
$2.75B
AUM Growth
+$244M
Cap. Flow
+$1.32M
Cap. Flow %
0.05%
Top 10 Hldgs %
34.07%
Holding
425
New
34
Increased
204
Reduced
126
Closed
25

Top Sells

Rank Stock Value
1
KO icon
Coca-Cola
KO
+$27.9M
2
TMO icon
Thermo Fisher Scientific
TMO
+$9.11M
3
XOM icon
ExxonMobil
XOM
+$8.66M
4
UNH icon
UnitedHealth
UNH
+$7.74M
5
NEE icon
NextEra Energy
NEE
+$5.7M

Sector Composition

Rank Sector Weight
1 Technology 25.02%
2 Financials 10.77%
3 Healthcare 10.07%
4 Consumer Discretionary 8.12%
5 Industrials 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QDF icon
301
FlexShares Quality Dividend Index Fund
QDF
$2.27B
$884K 0.03%
12,074
-4,613
-28% -$316K
COGT icon
302
Cogent Biosciences
COGT
$7.14B
$862K 0.03%
+120,011
New +$665K
REXR icon
303
Rexford Industrial Realty
REXR
$8.14B
$860K 0.03%
24,172
+1,442
+6% +$50.3K
GMED icon
304
Globus Medical
GMED
$11B
$841K 0.03%
14,245
+254
+2% +$16.4K
KR icon
305
Kroger
KR
$35.1B
$802K 0.03%
11,600
-400
-3% -$27.6K
SYRE icon
306
Spyre Therapeutics
SYRE
$9.12B
$787K 0.03%
52,546
+702
+1% +$10.4K
EPC icon
307
Edgewell Personal Care
EPC
$1.3B
$751K 0.03%
32,091
-149
-0.5% -$4.13K
UTHR icon
308
United Therapeutics
UTHR
$22.6B
$741K 0.03%
2,580
+33
+1% +$9.86K
SVRA icon
309
Savara
SVRA
$1.19B
$718K 0.03%
314,846
+91,830
+41% +$250K
SPMD icon
310
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.6B
$716K 0.03%
13,143
VCSH icon
311
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$689K 0.03%
8,671
ENR icon
312
Energizer
ENR
$1.48B
$650K 0.02%
32,261
-107
-0.3% -$2.57K
IWO icon
313
iShares Russell 2000 Growth ETF
IWO
$14.8B
$644K 0.02%
2,254
PAA icon
314
Plains All American Pipeline
PAA
$16.6B
$635K 0.02%
34,686
SHY icon
315
iShares 1-3 Year Treasury Bond ETF
SHY
$25.1B
$621K 0.02%
7,610
NVCR icon
316
NovoCure
NVCR
$1.83B
$615K 0.02%
34,560
+461
+1% +$8.03K
TFC icon
317
Truist Financial
TFC
$64.2B
$603K 0.02%
13,994
-754
-5% -$29.5K
PM icon
318
Philip Morris
PM
$293B
$583K 0.02%
3,203
-369
-10% -$63.4K
GSG icon
319
iShares S&P GSCI Commodity-Indexed Trust
GSG
$968M
$577K 0.02%
26,166
AB icon
320
AllianceBernstein
AB
$3.47B
$550K 0.02%
13,465
BOX icon
321
Box
BOX
$4.41B
$546K 0.02%
15,966
-229
-1% -$7.51K
TKO icon
322
TKO Group
TKO
$13.7B
$530K 0.02%
2,913
+38
+1% +$6.1K
VOT icon
323
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.6B
$530K 0.02%
1,862
-200
-10% -$51.6K
HLNE icon
324
Hamilton Lane
HLNE
$5.43B
$524K 0.02%
3,685
+25
+0.7% +$3.77K
BKNG icon
325
Booking.com
BKNG
$156B
$492K 0.02%
2,125
-10,525
-83% -$2.16M

Similar funds

F/M Investments's Q2 2025 Portfolio in Review

As of Q2 2025, F/M Investments held 425 positions worth $2.75B, up 9.7% from $2.51B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

F/M Investments's Q2 2025 filing shows 34 new, 204 increased, 126 reduced and 25 closed positions. Its largest new stake was F/m Ultrashort Treasury Inflation-Protected Security (TIPS) ETF: 197,898 shares worth $9.91M. The largest sale was Coca-Cola, an estimated $27.9M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • F/M Investments's largest Q2 2025 buy was F/m Ultrashort Treasury Inflation-Protected Security (TIPS) ETF: 197,898 shares worth $9.91M.
  • F/M Investments added most to F/m US Treasury 3 Month Bill Fund in Q2 2025, an estimated $12M increase.
  • F/M Investments's biggest Q2 2025 reduction was Coca-Cola, cutting an estimated $27.9M.
  • F/M Investments fully exited Thermo Fisher Scientific in Q2 2025, selling an estimated $9.11M.
  • F/M Investments's ten largest holdings make up 34% of its $2.75B portfolio in Q2 2025.
  • F/M Investments opened 34 new positions and closed 25 in Q2 2025.
  • F/M Investments's portfolio value rose 9.7% quarter-over-quarter to $2.75B.

Based on F/M Investments's 13F filing for Q2 2025, filed 13 Aug 2025.